Benquinox
CAS: 495-73-8
Ref. 3D-AAA49573
| 1g | 1,855.00 € | ||
| 2g | 2,783.00 € | ||
| 5g | 5,796.00 € | ||
| 250mg | 832.00 € | ||
| 500mg | 1,218.00 € |
Product Information
- 1,4-Benzoquinone 1-benzoylhydrazone 4-oxime
- 1,4-Benzoquinone N′-benzoylhydrazone oxime
- Bayer 15080
- Benzoic acid, (4-oxo-2,5-cyclohexadien-1-ylidene)hydrazide 4-oxime
- Benzoic acid, (4-oxo-2,5-cyclohexadien-1-ylidene)hydrazide, oxime
- Benzoic acid, 2-[4-(hydroxyimino)-2,5-cyclohexadien-1-ylidene]hydrazide
- Benzoic acid, [4-(hydroxyimino)-2,5-cyclohexadien-1-ylidene]hydrazide
- Ceredon
- Ceredon T
- Cerenox
- See more synonyms
- Lerenox
- N'-(4-nitrosophenyl)benzohydrazide
- N'-[(1E,4E)-4-(hydroxyimino)cyclohexa-2,5-dien-1-ylidene]benzohydrazide
- P-Benzoquinone 1-Benzoylhydrazon-4-Oxime
- Quinone oxime benzoylhydrazone
- p-Benzoquinone oxime benzoylhydrazone
Benquinox is a potent inhibitor of protein kinases that has shown promise in the treatment of cancer. It works by blocking the activity of certain kinases that are involved in cell growth and division, leading to apoptosis (programmed cell death) in cancer cells. Benquinox is an analog of donepezil, a drug used to treat Alzheimer's disease. Studies have shown that Benquinox inhibits tumor growth and induces apoptosis in human cancer cell lines. It has also been found to be effective against urinary tract tumors in Chinese patients. As an anticancer agent, Benquinox is being investigated for its potential use as a targeted therapy for various types of cancer. Its ability to inhibit kinases makes it a promising candidate for combination therapies with other kinase inhibitors.
Chemical properties
Technical inquiry about: 3D-AAA49573 Benquinox
If you want to request a quotation or place an order, please instead add the desired products to your cart and then request a quotation or order from the cart. It is faster, cheaper, and you will be able to benefit from the available discounts and other advantages.
